Table 3. Logistic regression analysis of complications and postoperative mortality.
| Variables | Odds ratio (95%CI)a (RM vs. CO) |
Odds ratio (95%CI)a (CM vs. CO) |
Odds ratio (95%CI)a (RM vs. CM) |
|||||
|---|---|---|---|---|---|---|---|---|
| CO | RM | CO | CM | CM | RM | |||
| Surgical complications | 1 (reference) | 1.44 (0.600–3.450) | 1 (reference) | 1.73 (0.650–4.610) | 1 (reference) | 0.82 (0.350–1.940) | ||
| Nonsurgical complications | 1 (reference) | 0.45 (0.200–1.040) | 1 (reference) | 0.41 (0.150–1.160) | 1 (reference) | 1.06 (0.380–2.950) | ||
| Clavien-Dindo grade IIIb or higher | 1 (reference) | 0.54 (0.210–1.413) | 1 (reference) | 0.53 (0.170–1.670) | 1 (reference) | 1.00 (0.330–3.110) | ||
| 90-day mortality | 1 (reference) | 0.69 (0.090–5.470) | 1 (reference) | 0.53 (0.040–6.980) | 1 (reference) | 1.13 (0.100–13.080) | ||
a, adjusted for age, ASA grade, cT, cN and tumor location. nCT, neoadjuvant chemotherapy; nCRT, neoadjuvant chemoradiotherapy; MIE, minimally invasive esophagectomy; OE, open esophagectomy; ASA, American Society of Anesthesiologists; cT, clinical T stage; cN, clinical N stage.